News
These conditions can make breathing more difficult — especially for people with asthma and chronic obstructive pulmonary disease, or COPD — and increase the use of inhalers.
The FDA approved the generic version, Wixela Inhub (fluticasone-salmeterol; Viatris), as the first generic maintenance inhaler for asthma and chronic obstructive pulmonary disease (COPD) in 2019 ...
Shifting from a metered-dose inhaler to a dry-powder inhaler for chronic obstructive pulmonary disease (COPD) and asthma in one healthcare system formulary led to increased healthcare utilization ...
Hosted on MSN10mon
Inhalers: Lifesavers for Patients, Silent Killers for the Planet
But few would suspect that a critical medical device for millions of people with asthma and COPD—asthma inhalers—could be silently exacerbating the climate crisis. The Environmental Impa ...
Both COPD and asthma are common diseases that affect a person's breathing. According to the Centers for Disease Control and Prevention, 15.7 million Americans report being diagnosed with COPD.
A 2017 study looked at around 2,600 Medicare Part D and Medicare Advantage plans to determine the average out-of-pocket costs for COPD inhalers. Depending on the inhaler type, costs ranged from ...
Inhalers are handheld devices that deliver medication through your mouth and lungs. They reduce inflammation in your airways and ease breathing, making them important treatments for asthma and COPD.
Metered-dose inhalers, the most common type used to treat asthma or chronic obstructive pulmonary disease (COPD), use a propellant gas to aerosolize medications, which patients then breathe in.
A new inhaler that treats chronic obstructive pulmonary disease (COPD) and also helps reduce environmental harm has been approved for use in the UK. This inhaler is already available in India ...
Many people with asthma and chronic obstructive pulmonary disease (COPD) can’t afford the costs of inhalers, a Respiratory Health Association executive writes. Illinois has capped co-pays for ...
For some, dry powder isn't a good option because not all asthma or COPD sufferers can get their medications in this form. And dry powder inhalers aren't recommended for young children or elderly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results